Vertex Pharmaceuticals (VRTX) reports Q4 earnings today. Investors are eager for updates on new drug launches and growth ...

CRISPR Therapeutics CRSP is expected to report fourth-quarter and full-year 2024 earnings later this month. The Zacks ...

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) reported Q4 CY2024 results exceeding the market’s revenue expectations , with sales up 15.7% year on year to $2.91 billion. The company ...

Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INC (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our P/B Growth Investor model based on the published ...

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting results tomorrow afternoon. Here’s what to look for. Vertex Pharmaceuticals beat analysts’ revenue expectations by 3.2% ...

In a report released yesterday, Jessica Fye from J.P. Morgan maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), with a price target of $501.00. The company’s shares ...

When Samsung teased the Galaxy S25 Edge during its Unpacked event in January, the company only teased the super-thin phone without revealing anything about it. We've seen some specs leaked about ...

State law has tried to bring more transparency to issues at North Carolina group homes that house adults living with mental ...

Two people were killed and two were hurt in a house fire in east Charlotte on Saturday morning, according to officials. The ...

CPI expected to have risen 0.3% on the month. McDonald's investors looking for earnings inflection. Elliott takes BP stake.